Graphene in Vaccines

Graphene in Vaccines refers to the body of research, independent analysis, and emerging scientific controversy surrounding the alleged or confirmed presence of graphene and graphene oxide (GO) within COVID-19 vaccine formulations. Beginning in 2021, a number of independent researchers, scientists, and laboratories claimed to have identified graphene-based structures — including graphene oxide (GO), reduced graphene oxide (rGO), graphene quantum dots (GQDs), and other carbon quantum dot variants — in vaccine vials using a range of analytical techniques. These claims have been vigorously contested by mainstream scientific institutions, yet continue to generate serious investigation among researchers focused on nanotechnology, biosurveillance, and the broader transhumanist agenda.

The presence of undisclosed graphene derivatives raises significant health and bioethical concerns. Graphene oxide is documented in peer-reviewed literature to be cytotoxic, thrombogenic, genotoxic, and capable of crossing the blood-brain barrier. If present in vaccine formulations without disclosure, it would represent a serious violation of bodily autonomy and informed consent. Some researchers go further, proposing that graphene's unique electromagnetic and self-assembling properties point to an intentional function: the seeding of an intra-body nanonetwork capable of biological surveillance and remote interaction.

Background: Why Graphene?

Graphene is a single-atom-thick layer of carbon atoms arranged in a hexagonal lattice. It is one of the strongest, most electrically conductive, and most versatile materials known to science. Graphene oxide (GO) is its chemically modified form — functionalised with oxygen groups that make it dispersible in water and compatible with biological systems.

In biomedical research, graphene oxide has attracted significant interest as:

A drug delivery vehicle capable of crossing biological barriers, including the blood-brain barrier
An adjuvant to enhance immune responses in vaccine formulations
A scaffold for brain-computer interface applications
A component in biosensors and diagnostic platforms

Given these known properties, some researchers argue it is scientifically plausible — even expected — that graphene-based materials would appear in next-generation pharmaceutical and vaccine platforms, particularly those developed under accelerated timelines with significant DARPA and Department of Defense funding.

The Campra Report

In November 2021, Dr. Pablo Campra, Professor of Applied Chemistry at the University of Almería, Spain, published a technical report titled Detection of Graphene in COVID19 Vaccines — one of the most methodologically detailed independent analyses of COVID-19 vaccine vials to date. The study employed micro-Raman spectroscopy, a well-established and highly sensitive technique for characterising carbon-based nanomaterials, to examine vials from four major COVID-19 vaccine manufacturers.

Methodology and Vaccine Brands Examined

Campra analysed samples from:

Pfizer-BioNTech (four separate batches)
AstraZeneca
Moderna
Janssen (Johnson & Johnson)

A total of 110 objects or regions of interest were screened across these samples. Of those:

28 objects produced Raman spectra showing features compatible with graphene-family materials
8 objects were conclusively identified as graphene oxide based on characteristic spectral signatures

Spectral Evidence

The identifying spectral signatures Campra documented included:

The G-band peak at approximately 1584 cm⁻¹ — characteristic of sp² carbon bonding in graphene structures
The D-band peak at approximately 1344 cm⁻¹ — indicative of structural defects consistent with graphene oxide chemistry
In some samples, a 2D-band consistent with few-layer graphene was also detected

These spectral fingerprints are the accepted standard in materials science for identifying graphene and graphene oxide. Campra noted that the declared ingredients of the examined vaccines — including lipid nanoparticles, polyethylene glycol (PEG), buffer salts, sucrose, and mRNA strands — do not include graphene or graphene oxide, and cannot account for the spectral patterns observed.

Carbon Quantum Dots and Graphene Quantum Dots as a Graphene-Family Subtype

An important and often underappreciated dimension of the Campra findings — and of related independent research by Corona2Inspect and La Quinta Columna — is the potential presence not only of bulk graphene oxide sheets but also of carbon quantum dots (CQDs) and, more specifically, graphene quantum dots (GQDs).

Graphene quantum dots are nanoscale fragments of the graphene lattice, typically 1–10 nanometres in lateral dimension. Like graphene oxide, they are built upon the same fundamental sp²-hybridised carbon lattice structure — a hexagonal arrangement of carbon atoms in which three electrons form planar sigma bonds and one electron occupies a delocalised pi orbital above and below the plane. This shared structural foundation means that:

GQDs and carbon quantum dots produce Raman spectroscopy signatures that closely overlap with those of graphene oxide — particularly the D-band (disorder) and G-band (graphitic sp² carbon) features that are diagnostic for the graphene family
Distinguishing GQDs from GO in a complex biological matrix using Raman spectroscopy alone requires careful attention to peak positions, ratios, and line widths — and misattribution between these subtypes is possible in preliminary analysis
Both GQDs and CQDs share GO's ability to function as photoluminescent probes, electrochemical sensors, and drug delivery vehicles at the nanoscale

This is significant for two reasons. First, it means that Campra's spectral findings — even if some objects represent GQDs or CQDs rather than bulk GO sheets — remain within the graphene-family of carbon nanomaterials, and the underlying concern about undisclosed carbon nanomaterial inclusions is not diminished. Second, it opens the possibility that the vaccine formulations may contain a spectrum of graphene-derived structures — ranging from macroscopic GO sheets to quantum-confined GQD particles — each with distinct biological and electromagnetic properties.

Corona2Inspect (researcher Mik Andersen) has specifically addressed the GQD question in his technical analyses, noting that graphene quantum dots have been extensively studied in the scientific literature as candidates for bioimaging, biosensing, and drug delivery — and that their small size and surface functionalisation make them particularly suited for biological dispersal and cellular penetration. He cross-references published patents and research papers describing GQD-based nanoscale sensor and communication architectures that align with the intra-body nanonetwork hypothesis.

La Quinta Columna's preliminary optical microscopy analysis, which preceded Campra's spectroscopic work, identified structures of varying scales — from large sheet-like formations down to bright point-like fluorescent objects consistent with the photoluminescent properties of carbon quantum dots and GQDs. Ricardo Delgado and colleagues argued that this size distribution across the graphene family was consistent with a multi-component nanonetwork design rather than simple contamination.

From a toxicological standpoint, the nanotoxicological profile of GQDs and CQDs is not identical to bulk GO. GQDs have been studied for their potential genotoxicity, oxidative stress induction, and capacity to interfere with cellular signalling pathways. Some studies suggest that their quantum-confined electronic properties may generate reactive oxygen species (ROS) more efficiently than bulk graphene, raising distinct health concerns. For a broader review of these risks, see Nanotoxicology and Nanoparticles in Vaccines.

The possibility that a cocktail of graphene-family nanomaterials — GO, rGO, GQDs, and CQDs — may be simultaneously present in vaccine formulations, each contributing different biological and electromagnetic functions, is a hypothesis that several independent researchers regard as consistent with the spectroscopic data and with the engineering requirements of a functional intra-body nanonetwork.

Role of Mik Andersen / Corona2Inspect

Complementing Campra's spectroscopic analysis, researcher Mik Andersen — writing under the pseudonym Corona2Inspect — contributed a parallel analysis focusing on the hydrogel medium observed in the vaccine samples. Andersen argued that the structures observed in the microscopy images were consistent with engineered hydrogel scaffolding of the type described in nano-bioelectronics research — capable of hosting and organising graphene-based nanocomponents. His work cross-references peer-reviewed literature and patents describing graphene-hydrogel composites for biological sensing and neural interface applications.

Campra explicitly called for urgent independent replication by academic institutions with no ties to pharmaceutical manufacturers, noting that his findings were preliminary but technically sound and warranted formal investigation. The report was submitted to Spain's health authority, AEMPS, as well as multiple academic bodies. No formal institutional response or replication attempt was publicly announced.

The report also drew significant attention from the Spanish research group La Quinta Columna, led by biostatistician Ricardo Delgado, which had published its own preliminary optical microscopy findings in June 2021 — findings that the Campra report substantially corroborated using more rigorous spectroscopic methodology.

Nanonetwork Hypothesis

Beyond the question of whether graphene is present, a more significant hypothesis has emerged: that its presence is not accidental contamination but functional design. Researchers working in the intersection of nanotechnology, telecommunications engineering, and biosurveillance have proposed that graphene-based materials introduced via vaccines could serve as the foundational components of an intra-body nanonetwork — a networked system of nanoscale devices operating within the human body.

This hypothesis draws on a robust body of academic literature in the field of the Internet of Nano-Things (IoNT) and is detailed extensively in the technical paper Vaccines Based on Graphene Nanonetwork and IoNT (attributed to researcher Kira Smith), which synthesises published scientific research to argue that the vaccine-delivered graphene compounds match the architectural requirements of a functioning nanocommunication network.

Network Architecture

The proposed nanonetwork architecture described in the IoNT paper includes:

Nanoantennas: Graphene's exceptional electromagnetic properties — particularly its ability to resonate in the terahertz (THz) frequency range — make it an ideal material for nanoscale antennas. GHz and THz-range signals, including those associated with 5G infrastructure, fall within the operational range of graphene nanoantennas.
Nanosensors: Graphene quantum dots (GQDs) and graphene-based field-effect transistors can function as molecular-scale sensors capable of detecting biochemical signals, neural activity, and physiological parameters.
Nanorouters: Larger graphene structures or quantum cellular automata (QCA)-based circuits can aggregate and route data signals between nano-nodes, functioning analogously to network routers at the nanoscale.
Nano-micro interface nodes: These structures bridge the gap between the nanoscale nanonetwork and macro-scale wireless communication infrastructure — enabling data collected within the body to be transmitted externally.

Communication Protocols

The paper details specific communication models proposed for intra-body nanonetworks:

TS-OOK (Time-Spread On-Off Keying): A modulation scheme proposed for THz-range nanocommunication, compatible with graphene nanoantenna properties. Short pulses of electromagnetic energy encode binary data between nano-nodes.
CORONA and DC-CORONA routing models: Proposed network routing protocols designed for the constrained, high-noise environment of an intra-body nanonetwork, allowing data packets to navigate between nanosensors and external receivers.
DRIH-MAC (Distance, Residual-energy and Interference-aware Hybrid MAC): A medium access control protocol proposed for body area nanonetworks, theoretically allowing multiple nano-nodes to share communication channels efficiently.

Graphene Quantum Dots and QCA Nanocircuits

Graphene Quantum Dots (GQDs) are nanoscale fragments of graphene with quantum mechanical properties distinct from bulk graphene. According to the IoNT paper:

GQDs can function as qubits or logic elements in quantum cellular automata (QCA) nanocircuits
QCA-based nanocircuits require no electrical current flow — they operate through electrostatic field interactions between quantum dots, making them exceptionally energy-efficient and difficult to detect by conventional means
Researchers including Campra reportedly observed structures under electron microscopy consistent with QCA-type nanocircuit configurations

These components, in combination, could theoretically constitute a self-powered, self-organising computing and communication network operating entirely within biological tissue — interfacing with the external world via electromagnetic fields in the GHz/THz range.

Cross-reference: Intra-Body Nano Network · Internet of Bodies · Body Area Network · MAC Address · 5G · IEEE 802.15.6

Self-Assembly

A critical feature of the nanonetwork hypothesis is that the network components do not need to be pre-assembled before introduction into the body. Graphene and graphene oxide are documented in peer-reviewed literature to be capable of self-assembly — spontaneously organising into functional structures under appropriate chemical, thermal, or electromagnetic conditions.

Relevant self-assembly mechanisms include:

DNA origami patterning: Graphene nanostructures can be guided into precise geometric configurations using DNA strand hybridisation — a technique extensively documented in the scientific literature and explored by DARPA-funded research programmes. DNA origami provides a programmable scaffold onto which graphene components attach in predetermined arrangements.
Electrophoresis: Electric fields cause charged graphene oxide sheets to migrate and align, enabling directed assembly into networked structures.
Teslaphoresis: A phenomenon documented by researchers at Rice University (James Tour's group) whereby carbon nanotubes and graphene structures self-organise and align in response to Tesla coil-generated electromagnetic fields — even across macroscopic distances. This raises the theoretical possibility that external electromagnetic signals (including those from 5G infrastructure) could trigger or direct assembly of graphene components in vivo.
Hydrogel-mediated assembly: Within a hydrogel matrix (as described in Mik Andersen's analysis of the vaccine samples), graphene components can achieve guided self-organisation supported by the gel's polymer network.

Ricardo Delgado of La Quinta Columna reported observing what appeared to be nanocircuit formation in dried Pfizer vaccine samples when these samples were exposed to external electromagnetic fields — structures that were not present or were disorganised in unperturbed samples. These observations, while contested, are consistent with the teslaphoresis and electrophoresis mechanisms described above.

Health Risks

The toxicological profile of graphene and graphene oxide in biological systems has been studied in the peer-reviewed literature independently of the vaccine controversy. Documented and alleged health risks include:

Thrombogenicity and Cardiovascular Effects

Graphene oxide has been shown in vitro and in vivo to activate platelets and promote blood clot formation (thrombogenesis)
GO has been reported to interfere with clotting cascade proteins, potentially explaining some post-vaccination cardiovascular events
Embalmers in several countries reported unusual fibrous, rubbery clots in deceased vaccinated individuals — structures some researchers have linked to graphene-scaffolded self-assembled materials

Genotoxicity and Mutagenicity

Multiple studies have reported that graphene oxide can cause DNA strand breaks and chromosomal aberrations in exposed cell lines
Genotoxic effects raise concerns about long-term mutagenic potential, including oncogenic risk

Pulmonary Toxicity

Inhaled or systemically circulating GO nanoparticles have been associated with pulmonary inflammation and fibrosis in animal studies
This is particularly relevant given the potential for graphene-containing aerosols (see stratospheric aerosol injection research)

Neurological Effects

GO crosses the blood-brain barrier in animal models
Once in neural tissue, GO has been observed to alter synaptic signalling and neuronal membrane properties
These findings are of particular concern given the alleged nanonetwork hypothesis and its implications for neural monitoring — see Neuroweapons and Remote Neural Monitoring

Immunosuppression and Immune Dysregulation

At certain concentrations, GO suppresses T-cell proliferation and NK cell activity
This immunosuppressive effect could theoretically explain post-vaccination immune dysregulation reported in some clinical case series

Apoptosis and Cytotoxicity

GO induces apoptosis (programmed cell death) in multiple cell types above threshold concentrations via oxidative stress pathways and mitochondrial membrane disruption

Robert O. Young's Parallel Findings

Dr. Robert O. Young, a researcher who has published extensive work on blood morphology and vaccine contents, reported finding graphene nanotubes and other carbon-based structures in COVID-19 vaccine vials using phase contrast and darkfield microscopy. He linked the presence of these materials to the rouleaux formation and abnormal coagulation patterns observed in the blood of vaccinated individuals — observations that parallel those reported by Dr. Ana Maria Mihalcea.

Cross-reference: Nanotoxicology · Embalmer Findings · Self-Assembling Nanostructures · Morgellons · Nanoparticles in Vaccines

MAC Address Phenomenon

Some researchers and Targeted Individual communities have reported a phenomenon whereby Bluetooth-scanning devices detect anonymous MAC addresses in the vicinity of recently vaccinated individuals — addresses that do not correspond to any declared consumer electronic device. This has been interpreted by some as evidence that the alleged intra-body nanonetwork is operational and broadcasting identification signals.

In the framework of the IoNT nanonetwork hypothesis, this would be consistent with the DRIH-MAC protocol model described in the technical literature, whereby nano-micro interface nodes within the body transmit data packets — including device identifiers — via wireless protocols compatible with Body Area Network standards such as IEEE 802.15.6.

Proponents argue that:

The MAC addresses detected near vaccinated individuals change over time, consistent with dynamic address allocation in a networked system
Addresses disappear after the death of the host, consistent with a biologically powered transmitter
The signal strengths and frequencies observed are consistent with Body Area Network communication specifications

Sceptics note that:

Modern environments contain large numbers of legitimate Bluetooth devices that may not be immediately visible to users
Standard Bluetooth MAC address randomisation (used in modern smartphones for privacy) could account for apparently anonymous addresses
No controlled experiment has yet demonstrated statistical significance of the effect

Regardless of interpretation, the MAC address phenomenon has become a significant focal point of independent researcher investigation into the alleged nanonetwork and is directly connected to the broader Internet of Bodies framework.

Cross-reference: MAC Address · Body Area Network · Intra-Body Nano Network · IEEE 802.15.6 · 5G

La Quinta Columna and Ricardo Delgado

The first high-profile claim that graphene oxide had been detected in COVID-19 vaccine vials came from the Spanish research group La Quinta Columna (The Fifth Column), led by biostatistician Ricardo Delgado and Dr. José Luis Sevillano. In June 2021, the group released a preliminary report claiming that a sample of the Pfizer-BioNTech vaccine had been analysed and found to contain approximately 99% graphene oxide by mass of the non-aqueous content.

The group presented optical microscopy images of the vaccine material, claiming that the structures observed were consistent with graphene oxide nanosheets. They connected these findings to reported symptoms in vaccinated individuals — including clotting, neurological effects, and cardiovascular anomalies — and argued that GO toxicity was responsible.

La Quinta Columna further alleged that graphene oxide was being used as:

A signal-reception antenna within the body, responsive to 5G electromagnetic frequencies
A mechanism enabling remote biological monitoring and interface
A pathway toward the intra-body nano network

While their methodology was criticised for lacking the rigour of peer-reviewed analysis, their claims prompted a wave of independent investigation by scientists in multiple countries — including the Campra micro-Raman spectroscopy study detailed above.

Dr. Shimon Yanowitz: Electrical Conductivity Findings

Israeli engineer and researcher Dr. Shimon Yanowitz conducted a separate series of experiments focusing on the electrical conductivity of COVID-19 vaccine contents. Yanowitz reported that fresh vaccine material demonstrated measurable electrical conduction properties inconsistent with a simple lipid nanoparticle and mRNA suspension.

According to Yanowitz's presentations and reports:

Vaccine vials, when subjected to electrical probing, displayed conductance behaviour suggesting the presence of metallic or semiconducting nanostructures
Structures observed under darkfield microscopy appeared to change shape or reorganise when electrical fields were applied
Some structures appeared to self-assemble or elongate over time, particularly when warmed to body temperature

Yanowitz connected these findings to the broader theory of self-assembling nanostructures potentially present in vaccine formulations, suggesting that graphene oxide might serve as a structural or conductive scaffold within these assemblies.

Dr. Ana Maria Mihalcea: Darkfield Microscopy and Blood Analysis

Dr. Ana Maria Mihalcea, a physician and researcher who has published extensively on anomalous structures in the blood of vaccinated individuals, reported findings using darkfield microscopy and live blood analysis that she interprets as consistent with graphene-based contamination or deliberate inclusion.

Her documented observations include:

Bright, highly reflective filamentous and crystalline structures in live blood samples of vaccinated individuals not seen (or rarely seen) in unvaccinated controls
Structures that appear to grow or self-organise over time in vitro
Geometric and lattice-like formations she describes as consistent with the morphology of graphene oxide sheets or carbon nanotube networks
Abnormal clumping and rouleaux formation in red blood cells in the presence of these structures

Mihalcea has written and spoken extensively about the connection between these findings and the theoretical framework of the intra-body nano network, as articulated by researchers such as Mik Andersen and others working under the biosensor/BAN hypothesis.

She has also documented what she describes as partial reversal of these anomalies using EDTA chelation therapy, which she interprets as evidence that the structures contain metallic or semiconducting elements — potentially consistent with graphene oxide chemistry.

Her work links to the broader research of Dr. Pablo Campra and others in forming what some call a converging body of independent evidence.

Potential Biological Effects of Graphene Oxide

Published peer-reviewed research — independent of the vaccine controversy — has extensively documented the biological effects of graphene oxide when introduced into living systems. Some findings include:

Cytotoxicity

GO has been shown to induce oxidative stress and mitochondrial damage in cell lines at certain concentrations
At high doses, GO disrupts cellular membranes and induces apoptosis (programmed cell death)

Haematological Effects

GO has been documented to cause aggregation of red blood cells (rouleaux) and platelet activation in vitro
Some studies report interference with clotting cascades, potentially relevant to post-vaccination thrombotic events

Neurological Penetration

GO nanoparticles have been shown in animal studies to cross the blood-brain barrier
Once in neural tissue, GO can alter neuronal signalling and has been studied as a substrate for neural interfaces

Electromagnetic Sensitivity

Graphene's exceptional electromagnetic properties mean that GO in tissue could theoretically interact with external radiofrequency fields — a claim that underpins much of the 5G-vaccine connection theory

Immune System Interaction

At low doses, GO has been proposed as an immune adjuvant — enhancing the antigen response in vaccine platforms
Some researchers argue this is precisely why it would be a valuable (if undisclosed) additive in mRNA vaccine formulations

Why Graphene Oxide Might Be Used in Vaccine Formulations

Researchers who accept the graphene hypothesis argue that GO offers several advantages as an undisclosed adjunct:

Enhanced mRNA delivery: GO can protect mRNA from enzymatic degradation and facilitate cellular uptake — complementing or replacing aspects of lipid nanoparticle delivery
Adjuvant effect: Strong innate immune activation without requiring traditional adjuvants like aluminium salts
Bioelectronic interface: If the longer-term goal involves biological monitoring or interface — as some researchers allege — graphene provides an ideal conductive substrate that can persist in tissue
Self-assembly potential: GO has well-documented tendencies to self-organise into sheets, networks, and structures under certain chemical and thermal conditions — relevant to self-assembling nanostructure hypotheses
Nanonetwork substrate: As detailed in the IoNT technical literature, graphene-based materials meet all the material requirements for the nanosensor, nanoantenna, and nanorouter components of an intra-body nanonetwork

Regulatory Context

Graphene, graphene oxide, and reduced graphene oxide are absent from all official declared ingredient lists for COVID-19 vaccines approved under Emergency Use Authorisation — including those from Pfizer-BioNTech, Moderna, AstraZeneca, and Janssen. Regulatory agencies including the European Medicines Agency (EMA) and the FDA have stated categorically that vaccine formulations do not contain graphene derivatives.

Critics and independent researchers raise the following concerns about this regulatory assurance:

Original regulatory submissions for mRNA vaccines under Emergency Use Authorisation were not fully disclosed — redacted versions were released to the public, limiting independent verification of declared ingredients
Standard pharmaceutical quality control processes were not designed to screen for undeclared nanotechnology components, particularly at nanogram-per-millilitre concentrations
The speed of regulatory approval under EUA conditions (months rather than the standard years) reduced the thoroughness of independent ingredient verification
Regulatory capture — the documented phenomenon of revolving-door relationships between regulatory agencies and the pharmaceutical industry — represents a structural conflict of interest in evaluating safety claims

Campra explicitly requested that his findings be subjected to independent replication using the same micro-Raman spectroscopy methodology. No publicly documented attempt at formal replication by an independent academic institution has been announced as of the time of writing.

Cross-reference: Regulatory Capture · Medical Regulation Failures · COVID Vaccines · Bodily Autonomy · Informed Consent · Nanoparticles in Vaccines

Mainstream Scientific Response

The mainstream scientific community has broadly rejected claims of graphene oxide in vaccines. Key counterarguments include:

Independent laboratory analyses commissioned by health authorities in multiple countries reported no detection of graphene oxide in the examined vials
Raman spectroscopy findings by Campra have been attributed to contamination artefacts or misinterpretation of carbon-based signals from the syringe or biological material
Regulatory agencies including the European Medicines Agency (EMA) and the FDA state that vaccine ingredient lists do not include graphene or graphene oxide
Mainstream fact-checkers classified the La Quinta Columna report as misinformation

Supporters of the independent research counter that:

Official analyses were conducted by parties with institutional conflicts of interest
The declared ingredient lists for novel mRNA vaccines were not fully disclosed in original regulatory submissions
Standard quality control processes may not screen for undeclared nanotechnology components
Replication has not been genuinely attempted by independent academic institutions with no ties to pharmaceutical manufacturers

Connection to Self-Assembling Nanostructures and Intra-Body Nano Network

The graphene-in-vaccines hypothesis connects directly to the broader theoretical framework of the intra-body nano network — the idea that nanotechnology introduced into the body (via vaccines, chemtrails, or other vectors) can self-assemble into functional communication and monitoring networks operating within the IEEE 802.15.6 Body Area Network standard.

In this framework, graphene oxide would serve as:

A conductive substrate enabling signal transmission between nano-nodes
A biosensor interface capable of reading biological data (neural signals, biochemical markers)
An antenna material capable of receiving and transmitting signals in the GHz/THz frequency range
A structural scaffold around which other self-assembling components organise

Researchers such as Mik Andersen (writing as Corona2Inspect) have produced detailed technical analyses arguing that the structures observed by Campra, Yanowitz, and Mihalcea are consistent with known engineered nano-network architectures described in patents and academic literature — including work funded by DARPA and described in DARPA's human enhancement programmes.

Anonymous

Search